Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-100689
Filing Date
2025-07-31
Accepted
2025-07-31 11:57:08
Documents
1
Period of Report
2025-07-31

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 11653
  Complete submission text file 0000950170-25-100689.txt   13066
Mailing Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
Benecchi Christopher (Reporting) CIK: 0001881403 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36544 | Film No.: 251170427